Safotibant

DB19469ExperimentalSmall molecule

Safotibant is a small molecule drug. The usage of the INN stem '-tibant' in the name indicates that Safotibant is a bradykinin receptor antagonist. Safotibant has a monoisotopic molecular weight...

Mechanism: Pharmacologically active on B1 bradykinin receptor
Curator reviewed
Formula / weight: C₂₅H₃₄N₄O₅S · 502.63 g/mol (avg)
Code names: FOV-2304 FREE BASE · LF 22-0542

Resolves to

Compound

UNII02HU8HWP7UCAS633698-99-4ChEMBLCHEMBL1254771

Structure

InChIKeyAMTQCENHQIDBHQ-UHFFFAOYSA-NSMILESCOC1=CC(C)=C(C(C)=C1)S(=O)(=O)N(C)CCOCC(=O)N(C)CC1=CC=C(C=C1)C1=NCCN1

Targets

P46663BDKRB1

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Safotibant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account